ENTYVIO® Outcomes in Real-world, Bio-naïve Ulcerative Colitis and Crohn’s Disease Patients (EVOLVE)—Greece (EVOLVE-Greece)

First published 19/07/2017

Last updated 23/04/2024

EU PAS number:

EUPAS19669

Study

Finalised

Download as PDF

Documents

Study protocol

Study results

Study results

Vedolizumab-5036 - Takeda EVOLVE_redacted

English (145.72 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Conflicts of interest of investigators

GJM CoI

English (10.87 KB - PDF)View document